Dietary fatty acid quality affects AR and PPARγ levels and prostate growth

Prostate

Volumn 69, Issue 5, 2009, Pages 548-558

  Escobar, Esdras L O ^a   Gomes Marcondes, Maria Cristina C ^a   Carvalho, Hernandes F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Androgen receptor; Diet; Fatty acids; Lard; Linseed oil; PPAR ; Prostate

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; LARD; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SOYBEAN OIL; TESTOSTERONE; FATTY ACID; LINSEED OIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; DIET; ESTRADIOL BLOOD LEVEL; FAT INTAKE; IMMUNOLOCALIZATION; LINSEED; MALE; NONHUMAN; PORK; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RAT; TESTOSTERONE BLOOD LEVEL; TISSUE GROWTH; WEIGHT GAIN; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; HYPERPLASIA; METABOLISM; ORGAN SIZE; PATHOLOGY; PROSTATE; TESTIS; WISTAR RAT;

ANIMALS; BODY WEIGHT; DIETARY FATS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESTRADIOL; FATTY ACIDS; HYPERPLASIA; LINSEED OIL; MALE; ORGAN SIZE; PPAR GAMMA; PROSTATE; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN; SOYBEAN OIL; TESTIS; TESTOSTERONE;

EID: 61949483298     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20905     Document Type: Article

References (50)

1. Dhom G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol 1983;106:210-218. (Pubitemid 14214560)
2. Chaudry A, McClinton S, Moffat LEF, Wahle KWJ. Essential fatty acids distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer 1991;64:1157-1160.
3. Rowley KH, Mason MD. The aetiology and patogenesis of prostate cancer. Clin Oncol R Coll Radiol 1997;9:213-218.
4. Mamalakis G, Kafatos A, Karagelopoulos N, Andrikolopoulos N, Daskalopoulos G, Kranidis A. Prostate cancer vs hiperplasia: Relationships with prostatic and adipose tissue fatty acid composition. Prostagl Leukotr Essent Fatty Acids 2002;66:467-477.
5. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Cancer surveillance series: Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999;91:1017-1024.
6. Fleshner N, Bagnell PS, Klotz L, Venkateswaran V. Dietary fat and prostate cancer. J Urol 2004;171:19-24. (Pubitemid 38090417)
7. Shennan DH, Bishop OS. Diet and the mortality from malignant disease in 32 countries. West Indian Med J 1974;23:44-53.
8. Blair A, Fraumni JF Jr. Geographic pattern of prostatic cancer in the USA. J Cancer Inst 1978;61:1379-1384. (Pubitemid 9070670)
9. Carroll KK, Khor HT. Dietaty fat in relation to tumorigenesis. Prog Biochem Pharmacol 1975;10:308-353.
10. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: Current status. J Natl Cancer Inst 1999;91:414-428.
11. Myers CE, Ghosh J. Lipoxygenase inhibition in prostate cancer. Eur Urol 1999;35:395-398. (Pubitemid 29229539)
12. Zhu YS, Katz MD, McGinley I. Lessons from human genetic models. Bailleres Clin Endocrinol Metab 1998;12:83-113.
13. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-362.
14. Ross RK, Henderson BE. Do diets and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 1994;86:252-254.
15. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L, Taylor PR. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study. Am J Clin Nutr 1996;64:850-855.
16. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650. (Pubitemid 20356241)
17. Zhang B, Marcus SL, Sajjadi FG, Alvares K, Reddy JK, Subramani S, Rachubinski RA, Capone JP. Identification of a peroxisome proliferator- responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase 3-hydroxyacyl-CoA-dehydrogenase. Proc Natl Acad Sci USA 1992;89:7541-7545.
18. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W. Fatty acids eicosanoids are ligands for peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997;11:770-791.
19. Segawa Y, Yoshimura R, Hase T, Hase T, Nakatani T, Wada S, Kawahito Y, Kishimoto T, Sano H. Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate 2002;51:108-116.
20. Wilson TM, Lambert MH, Kliewer SA. Peroxissome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 2001;70:341-367. (Pubitemid 32662214)
21. Sporn MB, Suth N, Mangelsdorf DJ. Prospects for prevention and treatment of cancer with selective PPAR-gamma modulators (SPARMs). Trends Mol Med 2001;7:395-400. (Pubitemid 32823988)
22. Rosen ED, Spiegelman BM. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001;276:37731-37734. (Pubitemid 37384014)
23. Nwankwo JO, Robbins ME. Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells. Prostagl Leukotr Essent Fatty Acids 2001;64(4-5):241-245. (Pubitemid 32619998)
24. Han S, Roman J. Peroxisome proliferator-activated receptor gamma: A novel target for cancer therapeutics? Anticancer Drugs 2007;18(3):237-244.
25. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, Kantoff PW. Effects of ligand activation of peroxisome proliferator-activated receptor g human prostate cancer. Proc Natl Acad Sci USA 2000;97:10990-10995.
26. 12. Cell Growth Differ 2000;11:49-61.
27. Li WD, Lee JH, Price RA. The perosissome proliferator-activated receptor gamma 2Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose. Mol Genet Metab 2000;70:159-161. (Pubitemid 30460459)
28. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-1951.
29. Kondo Y, Homma Y, Aso Y, Kakisoe T. Promotional effect of two-generation exposure to high-fat diet on prostate carcinogenesis in aci/seg rats. Cancer Res 1994;54:6129-6132. (Pubitemid 24378643)
30. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995;87:1456-1462.
31. Garcia-Flórez M, Oliveira CA, Carvalho HF. Early effects of estrogen on the rat ventral prostate. Braz J Med Biol Res 2005;38:487-497. (Pubitemid 40691998)
32. Vilamaior PSL, Taboga SR, Carvalho HF. Postnatal growth of the ventral prostate in Wistar rats: A stereological and morphometrical study. Anat Rec 2006;288A:885-892.
33. Fritz WA, Wang J, Eltoum I, Lamartiniere CA. Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocr 2002;186:89-99. (Pubitemid 34189782)
34. Gad SC, Weil CS. Statistic for toxicologists. In: Wallace H, editor. Principles and methods of toxicology. New York: Raven Press; 1994. pp. 221-274.
35. Giles G, Ireland P. Diet, nutrition and prostate cancer. Int. J Cancer Suppl 1997;10:13-17. (Pubitemid 27305699)
36. Cai X, Haleem R, Oram S, Cyriac J, Jiang F, Grayhack JT, Kozlowski JM, Wang Z. High fat diet increases the weight of rat ventral prostate. Prostate 2001;49:1-8. (Pubitemid 32807942)
37. Cai G, Huang H, Shapiro E, Zhou H, Yeh S, Melamed J, Greco MA, Lee P. Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate. J Urol 2005;173:2190-2193. (Pubitemid 40675279)
38. Wahle KW, Heys SD. Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis. Prostagl Leukotr Essent Fatty Acids 2002;67:183-186.
39. Bidoli E, Talamini R, Bosetti C, Negri E, Maruzzi D, Montella M, Franceschi S, La Vecchia C. Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 2005;16:152-157.
40. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45. (Pubitemid 33741879)
41. Sciarra F, Toscano V. Role of estrogens in human benign prostatic hyperplasia. Arch Androl 2000;44:213-220. (Pubitemid 30347104)
42. Håå g P, Bektic J, Bartsch G, Klocker H, Eder IE. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 2005;96:251-258.
43. Freeman VL, Meydani M, Hur K, Flanigan RC. Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer 2004;101(12):2744-2754. (Pubitemid 39603182)
44. Bravi F, Bosetti C, Dal Maso L, Talamini R, Montella M, Negri E, Ramazzotti V, Franceschi S, La Vecchia C. Food groups and risk of benign prostatic hyperplasia. Urology 2006;67(1):73-79. (Pubitemid 43069259)
45. Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr 2004;134(12 Suppl):3427S-3430S.
46. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005;51:85-94. (Pubitemid 40040538)
47. Subbarayann V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG. Differential peroxisome proliferator-activated receptor-γ isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev 2004;13:1711-1716. (Pubitemid 39482946)
48. Cury-Boaventura FM, Kanunfre CC, Gorjão R, Martins de Lima T, Curi R. Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids. Clin Nutr 2006;25:1004-1014.
49. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 2004;62(9):333-339. (Pubitemid 39299134)
50. Murtaugh MA, Ma K, Caan BJ, Sweeney C, Wolff R, Samowitz WS, Potter JD, Slattery ML. Interactions of peroxisome proliferator-activated receptor, and diet in etiology of colorectal cancer epidemiol. Biomarkers Prev 2005;14:1224-1229. (Pubitemid 40656471)